Log In
BCIQ
Print this Print this
 

Nimbex, cisatracurium besylate

  Manage Alerts
Collapse Summary General Information
Company AbbVie Inc.
DescriptionNeuromuscular blocking agent
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase IV
Standard IndicationRespiratory distress syndrome (RDS)
Indication DetailsTreat acute respiratory distress syndrome (ARDS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today